Bridging the gap: Broadridge looks front-to-back with acquisition of Itiviti

The deal signals a transformative move for Broadridge into the front-office space to help clients simplify their front-to-back technology stack. But some industry observers are skeptical about how it will achieve this. 

When Broadridge Financial Solutions announced at the end of March that it was buying Itiviti from Nordic Capital for $2.5 billion, the price tag caught some off guard. The fact that it was Broadridge acquiring the Swedish trading platform provider surprised others. But this is the way the market is moving: large banks, large exchanges, and large vendors are all trying to figure out how they can create their own front-to-back ecosystem for users. 

Banks used to say that they weren’t technology

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

If you already have an account, please sign in here.

Waters Wrap: Examining ASX’s CHESS do-over

The Australian exchange was the first exchange to be all-in on DLT—and the project failed. Anthony speaks with ASX’s Tim Whiteley to discuss the lessons learned and why he thinks the second attempt will succeed.

GenAI and HFT: A competitive edge?

Timing is critical in the capital markets. IBM researchers say genAI’s predictive abilities in combination with AI/ML models can translate into profitable HFT opportunities.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here